With Alexion Pharmaceuticals, we created a Soliris mechanism of action animation for the treatment of Myasthenia Gravis (MG). MG is an autoimmune disorder characterized by neuromuscular transmission failure and subsequent voluntary muscle weakness.
Keywords: 3D, Video, Patient Education, Professional Education, Molecular Biology, Neuroscience, Mechanism of Action (MOA)
XVIVO